Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 3 recruiting now small index

Tourette Syndrome in Adolescence clinical trials

3 of 6 indexed Tourette Syndrome in Adolescence trials are currently recruiting.

Corpus placement: #2,866 of 28,707 conditions by registered trial count.

6 US clinical trials · 3 currently recruiting · #2,866 of 28,707 conditions by registered trial count

Tourette Syndrome in Adolescence: 6 US clinical trials tracked, 3 recruiting.

Tourette Syndrome in Adolescence is the subject of 6 registered US clinical trials on ClinicalTrials.gov, 3 of them currently open to new participants. The most active sponsor is University of Utah, running 2 of these trials.

Enrollment posture brief

Registry condition tourette-syndrome-in-adolescence

OPEN 3 | RECR 50% | LATE 0 | EARLY 0 | RANK #2866 | SPON 2

Nearest open-share peer: Achalasia (50% recruiting · 8 trials)

Acute Hypoxemic Respiratory 66.7%Abdominal Aortic Aneurysms50%Acupuncture50%Acute Lymphoblastic Leukemia50%Tourette Syndrome in Ado (th…50%
Open-enrollment share among volume-matched conditions near Tourette Syndrome in Adolescence

Tourette Syndrome in Adolescence lists 3 open slots (50% of 6 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Tourette Syndrome in Adolescence on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Tourette Syndrome in Adolescence is recruiting above its size-band peers.

    3 of 6 indexed trials (50%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

  2. One sponsor concentrates Tourette Syndrome in Adolescence research.

    University of Utah accounts for 2 of 6 trials (33.3%). 5 distinct sponsors appear on at least one study for this condition label.

  3. Most Tourette Syndrome in Adolescence trials plan to enrol fewer than 100 people.

    Median target enrolment is 50 among the 6 trials that report a genuine target (sentinel values excluded). 6 of those (100%) plan for fewer than 100 participants.

  4. Tourette Syndrome in Adolescence splits between interventional and observational designs.

    4 interventional and 2 observational studies make up this index (66.7% interventional). Study type is sponsor-reported on ClinicalTrials.gov.

Phase Distribution

Phase data not available

Named interventions

Most-linked intervention names on Tourette Syndrome in Adolescence records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

Continuous Theta Burst Stimulation (cTBS) Device
1 trials
Habit Reversal Training Behavioral
1 trials
Habit Reversal Training (HRT) Behavioral
1 trials
Comprehensive Behavioral Intervention for Tics (CBIT) Behavioral
1 trials
Neurofeedback from control region Other
1 trials
Neurofeedback from the SMA Other
1 trials
Repetitive Transcranial Magnetic Stimulation (rTMS) Device
1 trials

US sites by state

Facility locations filed on Tourette Syndrome in Adolescence trials. A trial with sites in several states counts in each.

Utah 2 trials
Tennessee 1 trials
North Carolina 1 trials
Minnesota 1 trials
Connecticut 1 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Tourette Syndrome in Adolescence page

6 registered trials, 3 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

  • 3 Tourette Syndrome in Adolescence trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
  • University of Utah sponsors the most Tourette Syndrome in Adolescence trials on record, review their full trial history before evaluating a specific study. See University of Utah's trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Tourette Syndrome in Adolescence condition card totals 6 registered trials; most-linked intervention Continuous Theta Burst Stimulation (cTBS); top US site state Utah. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.